Suppression of nitric oxide induction and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models
Tóm tắt
Inflammation has been implicated in a variety of diseases associated with ageing, including cancer, cardiovascular, and neurologic diseases. We have recently established that the proteasome is a pivotal regulator of inflammation, which modulates the induction of inflammatory mediators such as TNF-α, IL-1, IL-6, and nitric oxide (NO) in response to a variety of stimuli. The present study was undertaken to identify non-toxic proteasome inhibitors with the expectation that these compounds could potentially suppress the production of inflammatory mediators in ageing humans, thereby decreasing the risk of developing ageing related diseases. We evaluated the capacity of various proteasome inhibitors to suppress TNF-α, NO and gene suppression of TNF-α and iNOS mRNA, by LPS-stimulated macrophages from several sources. Further, we evaluated the mechanisms by which these agents suppress secretion of TNF-α, and NO production. Over the course of these studies, we measured the effects of various proteasome inhibitors on the RAW 264.7 cells, and peritoneal macrophages from four different strains of mice (C57BL/6, BALB/c, proteasome double subunits knockout LMP7/MECL-1-/-, and peroxisome proliferator-activated receptor-α-/- (PPAR-α-/-) knockout mice. We also directly measured the effect of these proteasome inhibitors on proteolytic activity of 20S rabbit muscle proteasomes. There was significant reduction of chymotrypsin-like activity of the 20S rabbit muscle proteasomes with dexamethasone (31%), mevinolin (19%), δ-tocotrienol (28%), riboflavin (34%), and quercetin (45%; P< 0.05). Moreover, quercetin, riboflavin, and δ-tocotrienol also inhibited chymotrypsin-like, trypsin-like and post-glutamase activities in RAW 264.7 whole cells. These compounds also inhibited LPS-stimulated NO production and TNF-α secretion, blocked the degradation of P-IκB protein, and decreased activation of NF-κB, in RAW 264.7 cells. All proteasome inhibitors tested also significantly inhibited NO production (30% to 60% reduction) by LPS-induced thioglycolate-elicited peritoneal macrophages derived from all four strains of mice. All five compounds also suppressed LPS-induced TNF-α secretion by macrophages from C57BL/6 and BALB/c mice. TNF-α secretion, however, was not suppressed by any of the three proteasome inhibitors tested (δ-tocotrienol, riboflavin, and quercetin) with LPS-induced macrophages from LMP7/MECL-1-/- and PPAR-α-/- knockout mice. Results of gene expression studies for TNF-α and iNOS were generally consistent with results obtained for TNF-α protein and NO production observed with four strains of mice. Results of the current study demonstrate that δ-tocotrienol, riboflavin, and quercetin inhibit NO production by LPS-stimulated macrophages of all four strains of mice, and TNF-α secretion only by LPS-stimulated macrophages of C57BL/6 and BALB/c mice. The mechanism for this inhibition appears to be decreased proteolytic degradation of P-IκB protein by the inhibited proteasome, resulting in decreased translocation of activated NF-κB to the nucleus, and depressed transcription of gene expression of TNF-α and iNOS. Further, these naturally-occurring proteasome inhibitors tested appear to be relatively potent inhibitors of multiple proteasome subunits in inflammatory proteasomes. Consequently, these agents could potentially suppress the production of inflammatory mediators in ageing humans, thereby decreasing the risk of developing a variety of ageing related diseases.
Tài liệu tham khảo
Knott AB, Bossy-Wetzel E: Impact of nitric oxide on metabolism in health and age-related disease. Diabetes Obesity & Metabolism. 2010, 12 (2): 126-133.
Chen LC, Pace JL, Russell SW, Morrison DC: Altered regulation of inducible nitric oxide synthase expression in macrophages from senescent mice. Infection and Immunity. 1996, 64 (10): 4288-4298.
Shen J, Reis J, Morrison DC, Papasian CJ, Sreekumar R, Kolbert C, Qureshi AA, Vogel SN, Qureshi N: Key Inflammatory signaling pathways are regulated by the proteasome. Shock. 2006, 25: 472-484. 10.1097/01.shk.0000209554.46704.64
Qureshi N, Perera PY, Splitter G, Morrison DC, Vogel SN: The Proteasome as a LPS-binding protein in macrophages: Toxic lipopolysaccharide activates the proteasome complex. J Immunol. 2003, 171: 1515-1525.
Suckerman SH, Qureshi N: In vivo inhibition of lipopolysaccharides-induced lethality and tumor necrosis factor synthesis by Rhodobactor sphaeroides diphosphoryl lipid A is dependent on corticosterone induction. Infect Immun. 1992, 60: 2581-2587.
Reis J, Tan X, Yang R, Qureshi AA, Papasian CJ, Vogel SN, Morrison DC, Qureshi N: A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model. Innate Immunity. 2008, 14 (5): 319-329. 10.1177/1753425908096855
Shen J, Gao JJ, Zhang G, Tan X, Morrison DC, Papasian CJ, Vogel SN, Qureshi N: Proteasome inhibitor, lactacystin blocks CpG DNA- and peptidoglycan induced inflammatory genes, cytokines and mitogen-activated protein kinases in macrophages. Shock. 2006, 25: 594-599. 10.1097/01.shk.0000209555.46704.2d
Qureshi N, Vogel SN, Way CV, Papasian CJ, Qureshi AA, Morrison DC: The proteasome: A central regulator of inflammation and macrophage function. Immunological Research. 2005, 31 (3): 243-260. 10.1385/IR:31:3:243.
Qureshi AA, Reis JC, Papasion CJ, Morrison DC, Qureshi N: Tocotrienols inhibit the lipopolysacharides-induced pro-inflammatory cytokines in macrophages of female mice. Lipids in Health and Diseases. 2010, 9: 143-10.1186/1476-511X-9-143. 10.1186/1476-511X-9-143
Qureshi AA, Reis JC, Qureshi N, Papasion CJ, Morrison DC, Schaefer DM: δ-Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens. Lipids in Health and diseases. 2011, 10: 39-10.1186/1476-511X-10-39. 10.1186/1476-511X-10-39
Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP, Leewenburgh C: Molecular inflammation: underpinnings of ageing and age-related diseases. Ageing Res Rev. 2009, 8: 18-30. 10.1016/j.arr.2008.07.002
Nair MP, Mahajan S, Reynolds JL, Aalinkeel R, Nair H, Schwartz SA, Kandaswami C: The flavonoid quercetin inhibits pro-inflammatry cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of NF-κB system. Clinical and Vaccine Immunology. 2006, 13 (3): 319-328. 10.1128/CVI.13.3.319-328.2006
Nam N: Naturally-occurring NF-κB inhibitors. Mini-Reviews in Medicinal Chemistry. 2006, 6: 945-951. 10.2174/138955706777934937
Shulman AI, Mangelsdorf DJ: Retinoid × receptor heterodimers in the metabolic syndrome. N Endl J Med. 2005, 353 (6): 604-615. 10.1056/NEJMra043590.
Chao C, Youssef J, Rezaiekhaleigh M, Birnbaum LS, Badr M: Senescence-associated decline in hepatic peroxisomal enzyme activities with diminished levels of retinoid × receptor alpha, but not peroxisome proliferator-activated receptor alpha. Mechanisms of ageing and development. 2002, 123: 1469-1476. 10.1016/S0047-6374(02)00086-6
Qureshi AA, Mo H, Packer L, Peterson DM: Isolation and structural identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant and antitumor properties. J Agr Food Chem. 2000, 48: 3130-3140. 10.1021/jf000099t.
Stuehr DJ, Nathan CF: Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med. 1989, 169: 1543-1555. 10.1084/jem.169.5.1543
Abraham E: NF-kappa B activation. Crit Carte Med. 2000, 28: N100-N104. 10.1097/00003246-200004001-00012.
Yubero S, Ramudo L, Manso MA, Dios ID: Mechanism of dexamethasone-mediated chemokine down-regulation in mild and severe acute pancreatitis. Biochimica et Biophysica Acta. 2009, 1792: 1205-1211.
Haddad JJ, Land SC: Amiloride blockades lipopolysaccharide-induced pro-inflammatory cytokine biosynthesis in an IκB/NF-κB-dependent mechanism. Evidence for the amplification of an anti-inflammatory pathway in the alveolar epithelium. Am J Respir Cell Mol Biol. 2002, 26: 114-126.
Chomczynski P, Saachi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ana Biochem. 1987, 162: 156-159.
Reis J, Guam XQ, Kisselev AF, Papasian CJ, Qureshi AA, Morrison DC, Van Way CW, Vogel SN, Qureshi N: LPS-induced formation of immunoproteasome: TNF-α and nitric oxide production are regulated by altered composition of proteasome-active sites. Cell Biochemistry and Biophysics. 2011, 60: 77-88. 10.1007/s12013-011-9182-8
Reis J, Hassan F, Guam XQ, Shen J, Monaco JJ, Papasian CJ, Qureshi AA, Van Way CW, Vogel SN, Morrison DC, Qureshi N: The immunoproteasome regulate LPS-induced TRIF/TRAM signaling pathway in murine macrophages. Cell Biochemistry and Biophysics. 2011, 60: 119-126. 10.1007/s12013-011-9183-7
Babaev VR, Ishiguro H, Ding L, Yancey PG, Dove DE, Kovacs WJ, Semenkovich CF, Fazio S, Linton MF: Macrophage expression of peroxisome proliferator-activated receptor-a reduces atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation. 2007, 116 (12): 1404-1412. 10.1161/CIRCULATIONAHA.106.684704
Bensinger SJ, Tontonoz P: Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature. 2008, 454 (7203): 470-477. 10.1038/nature07202
Genini D, Catapano CV: Control of peroxisome proliferator-activated receptor fate by the ubiquitin proteasome system. Journal of Receptors & Signal Transduction. 2006, 26 (5-6): 679-692. 10.1080/10799890600928202
Ahn KS, Sethi G, Krishnan K, Aggarwal BB: γ-Tocotrienol inhibits nuclear-κB signaling pathway through inhibition of receptor- interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. The J Biol Chem. 2007, 282 (1): 809-820.
Lin kI, Baraban JM, Ratan RR: Inhibition versus induction of apoptosis by proteasome inhibitors depend on concentration. Cell Death and Differentiation. 1998, 5: 577-583. 10.1038/sj.cdd.4400384